Our comprehensive in vitro and in vivo data convincingly revealed that PLCη2 and its C2 domain modulated the inflammatory and aggressive phenotypes of RA FLSs, thereby suppressing RA development and progression. This evidence concerns the gene PLCH2 and rheumatoid arthritis.